awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51023478-2FD0B42B-0E74-4C40-BA2E-F6E6642B27D0
Q51023478-2FD0B42B-0E74-4C40-BA2E-F6E6642B27D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51023478-2FD0B42B-0E74-4C40-BA2E-F6E6642B27D0
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib.
P2860
Q51023478-2FD0B42B-0E74-4C40-BA2E-F6E6642B27D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51023478-2FD0B42B-0E74-4C40-BA2E-F6E6642B27D0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ffafe39e9e3956113e92631625340631c89ce807
P2860
Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance.